Specific human endogenous retroviruses predict metastatic potential in uveal melanoma

Specific human endogenous retroviruses predict metastatic potential in uveal melanoma

Uveal melanoma (UM) is a unique disease in that patients with primary UM are well stratified based on their risk of developing metastasis, yet there are limited effective treatments once metastases occur. There is an urgent need to better understand the distinct molecular pathogenesis of UM and the...

Descripció completa

Dades bibliogràfiques
Autors principals:	Matthew L. Bendall, Jasmine H. Francis, Alexander N. Shoushtari, Douglas F. Nixon
Format:	Article
Idioma:	English
Publicat:	American Society for Clinical investigation 2022-05-01
Col·lecció:	JCI Insight
Matèries:	Microbiology Oncology
Accés en línia:	https://doi.org/10.1172/jci.insight.147172

Ítems similars

Meta-analysis of the gut microbiota in predicting response to cancer immunotherapy in metastatic melanoma
per: Angelo Limeta, et al.
Publicat: (2020-12-01)

Characterizing metastatic uveal melanoma patients who develop symptomatic brain metastases
per: Alexander Z. Wei, et al.
Publicat: (2022-09-01)

Multiregional genetic evolution of metastatic uveal melanoma
per: Daniel A. Rodriguez, et al.
Publicat: (2021-08-01)

Clearance of plasma cell free DNA in metastatic uveal melanoma with radiographic response to immune checkpoint inhibitors
per: Jasmine H. Francis, et al.
Publicat: (2024-06-01)

Human endogenous retrovirus onco-exaptation counters cancer cell senescence through calbindin
per: Jan Attig, et al.
Publicat: (2023-07-01)

Proteogenomic identification of an immunogenic antigen derived from human endogenous retrovirus in renal cell carcinoma
per: Shin Kobayashi, et al.
Publicat: (2023-08-01)

The Economic Value of MR-Imaging for Uveal Melanoma
per: Grech Fonk L, et al.
Publicat: (2020-04-01)

Human Endogenous Retrovirus Expression Is Associated with Head and Neck Cancer and Differential Survival
per: Allison R. Kolbe, et al.
Publicat: (2020-08-01)

Comprehensive analysis of chromosome 8 abnormalities and its prognostic value in patients with uveal melanoma
per: V. A. Yarovaya, et al.
Publicat: (2022-03-01)

Intermittent MEK inhibition for the treatment of metastatic uveal melanoma
per: Shaheer Khan, et al.
Publicat: (2022-09-01)

Prognostic fine needle aspiration biopsy of uveal melanoma: Molecular and genetic factors of metastasis risk
per: V. A. Yarovaya, et al.
Publicat: (2023-10-01)

Ribosomal profiling of human endogenous retroviruses in healthy tissues
per: Nicholas Dopkins, et al.
Publicat: (2024-01-01)

Hemorrhagic choroidal detachment as the presenting sign of uveal melanoma
per: Yewlin E. Chee, et al.
Publicat: (2021-09-01)

Human endogenous retrovirus expression landscape in models of HIV-1 latency
per: M. de Mulder Rougvie, et al.
Publicat: (2019-07-01)

Human-Specific Endogenous Retroviruses
per: Anton Buzdin
Publicat: (2007-01-01)

Paleovirology of human endogenous retroviruses
per: Gifford, R, et al.
Publicat: (2009)

Paleovirology of human endogenous retroviruses
per: Gifford, R, et al.
Publicat: (2009)

Artificial intelligence in the diagnosis of uveal melanoma: advances and applications
per: Albert K. Dadzie, et al.
Publicat: (2025-02-01)

Long-term survival follow-up for tebentafusp in previously treated metastatic uveal melanoma
per: Jessica C Hassel, et al.
Publicat: (2024-06-01)

Editorial: Uveal melanoma: from lab bench to clinic – new therapeutic advances
per: Agata Grazia D'Amico, et al.
Publicat: (2023-06-01)

538 Updated survival of patients with previously treated metastatic uveal melanoma who received tebentafusp
per: Joseph Sacco, et al.
Publicat: (2021-11-01)

Increased Histological Tumor Pigmentation in Uveal Melanoma Is Related to Eye Color and Loss of Chromosome 3/BAP1
per: Maria Chiara Gelmi, MD, et al.
Publicat: (2023-09-01)

Tissue-Based Microarray Expression of Genes Predictive of Metastasis in Uveal Melanoma and Differentially Expressed in Metastatic Uveal Melanoma
per: Hakan Demirci, et al.
Publicat: (2013-01-01)

Zebrafish Patient-Derived Xenograft Model as a Preclinical Platform for Uveal Melanoma Drug Discovery
per: Jie Yin, et al.
Publicat: (2023-04-01)

Tebentafusp: T cell redirection for the treatment of metastatic uveal melanoma
per: Damato, BE, et al.
Publicat: (2019)

Transarterial chemoembolization for patients with metastatic uveal melanoma in the liver
per: B. I. Dolgushin, et al.
Publicat: (2016-09-01)

The role of PET/CT in the diagnosis of metastatic uveal melanoma
per: S. V. Saakyan, et al.
Publicat: (2018-10-01)

Darovasertib, a novel treatment for metastatic uveal melanoma
per: Lei Cao, et al.
Publicat: (2023-07-01)

Molecular profiling of driver events in metastatic uveal melanoma
per: Joakim Karlsson, et al.
Publicat: (2020-04-01)

Human Endogenous Retrovirus K in Cancer: A Potential Biomarker and Immunotherapeutic Target
per: Gislaine Curty, et al.
Publicat: (2020-07-01)

Ipilimumab plus nivolumab for patients with metastatic uveal melanoma: a multicenter, retrospective study
per: Arun Singh, et al.
Publicat: (2020-05-01)

SARS-CoV-2 infection mediates differential expression of human endogenous retroviruses and long interspersed nuclear elements
per: Jez L. Marston, et al.
Publicat: (2021-12-01)

Tumor microenvironment (TME) features and serum cytokines in patients with metastatic uveal and cutaneous melanoma treated with tebentafusp
per: O. Hamid, et al.
Publicat: (2024-01-01)

Polypeptide analysis of a porcine C-type retrovirus
per: Hamdan, Hasnah, et al.
Publicat: (1981)

Tebentafusp: a first-in-class treatment for metastatic uveal melanoma
per: Sarah Howlett, et al.
Publicat: (2023-03-01)

Uveal Melanoma
per: Vasilios P. Papastefanou, et al.
Publicat: (2011-01-01)

The discovery of endogenous retroviruses
per: Weiss Robin A
Publicat: (2006-10-01)

Cerebellum-specific and age-dependent expression of an endogenous retrovirus with intact coding potential
per: Itoh Takayuki, et al.
Publicat: (2011-10-01)

Automatic Three-Dimensional Magnetic Resonance-based measurements of tumour prominence and basal diameter for treatment planning of uveal melanoma
per: Lisa Klaassen, et al.
Publicat: (2022-10-01)

Troponin Elevation in Patients Undergoing Percutaneous Hepatic Perfusion for Metastatic Uveal Melanoma
per: Sanjay Chandrasekhar, et al.
Publicat: (2024-04-01)